Lori A. Woods, Director at Perspective Therapeutics, Inc. (CATX), bought 34,246 shares at $1.46 ($50K) on 2024-06-03, disclosed to the SEC on 2024-06-04.
Open-market purchase of $50k CATX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| CATX | BUY | 2023-12-18 | $50K | — | Filing → |
| ISR | BUY | 2022-11-17 | $34K | — | Filing → |
| ISR | BUY | 2022-06-09 | $23K | — | Filing → |